Se încarcă…
Fiecare companie de aici trecută prin aceleași cinci verificări privind creșterea și generarea de numerar. Descrie industria așa cum raportează astăzi — nu pe care dintre acestea să o cumperi.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | C | 50,4B USD | 43,21 USD | 100,49 | 17,2B USD | 2,9 % |
| HLN | Haleon plc | B+ | 40,7B USD | 9,09 USD | 18,33 | 14,8B USD | 15,1 % |
| ZTS | Zoetis Inc. | C+ | 33,5B USD | 82,57 USD | 13,92 | 9,5B USD | 26,4 % |
| TAK | Takeda Pharmaceutical Company Limited | A | 33,5B USD | 20,86 USD | 48,79 | 29,8B USD | 0,9 % |
| UTHR | United Therapeutics Corporation | C+ | 25,4B USD | 595,58 USD | 22,48 | 3,2B USD | 38,6 % |
| VTRS | VIATRIS INC. | D | 24,1B USD | 21,06 USD | — | 14,7B USD | -23,9 % |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | A+ | 17,6B USD | 174,35 USD | 25,87 | 3,7B USD | 19,0 % |
| ELAN | Elanco Animal Health Incorporated | A | 13,2B USD | 26,48 USD | — | 5,1B USD | -2,9 % |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B | 12,4B USD | 14,83 USD | 20,77 | 3,5B USD | 4,4 % |
| KNSA | Kiniksa Pharmaceuticals International, plc | A+ | 8,1B USD | 95,80 USD | 73,13 | 946M USD | 11,6 % |
| ALKS | Alkermes plc. | C | 8B USD | 47,88 USD | — | 1,8B USD | -0,0 % |
| AMRX | Amneal Pharmaceuticals, Inc. | C | 7,6B USD | 21,72 USD | 51,71 | 3,2B USD | 4,2 % |
| LNTH | LANTHEUS HOLDINGS, INC. | B+ | 6,6B USD | 101,58 USD | 25,08 | 1,6B USD | 17,3 % |
| LQDA | LIQUIDIA CORPORATION | A | 5B USD | 55,19 USD | — | 621,9M USD | -15,1 % |
| HIMS | HIMS & HERS HEALTH, INC. | C- | 4,9B USD | 20,81 USD | — | 2,9B USD | -6,7 % |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | 4,1B USD | 31,78 USD | — | 0,00 USD | — |
| BHC | Bausch Health Companies Inc. | A | 3,1B USD | 8,35 USD | — | 11,1B USD | -7,6 % |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | 3B USD | 16,51 USD | — | 368,3M USD | -1,8 % |
| RGC | REGENCELL BIOSCIENCE HOLDINGS LIMITED | fără notă | 2,7B USD | 5,45 USD | — | — | — |
| HCM | HutchMED (China) LIMITED | D | 2,6B USD | 15,04 USD | — | 549,1M USD | 3,3 % |
| PRGO | Perrigo Company plc | F- | 2,3B USD | 16,56 USD | — | 4,1B USD | -43,3 % |
| TRLV | TRULIEVE CANNABIS CORP. | F | 2,3B USD | 11,24 USD | — | 1,1B USD | -41,3 % |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | 2,1B USD | 44,17 USD | 13,63 | 1,2B USD | 13,3 % |
| ETON | ETON PHARMACEUTICALS, INC. | A+ | 2B USD | 68,42 USD | — | 141,1M USD | 35,3 % |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | B | 2B USD | 7,65 USD | — | 961,5M USD | -37,4 % |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | 1,7B USD | 29,42 USD | — | 865,1M USD | -5,1 % |
| ANIP | ANI PHARMACEUTICALS, INC | B+ | 1,5B USD | 71,23 USD | 14,22 | 1B USD | 11,2 % |
| ALVO | ALVOTECH | B | 1,5B USD | 4,93 USD | 49,25 | 586,3M USD | 4,8 % |
| PCRX | PACIRA BIOSCIENCES, INC. | B | 1,5B USD | 36,47 USD | 39,22 | 743,3M USD | 5,1 % |
| PAHC | Phibro Animal Health Corporation | B | 1,4B USD | 35,13 USD | 14,00 | 1,5B USD | 6,7 % |
| CRON | CRONOS GROUP INC. | A | 1,3B USD | 3,46 USD | 20,32 | 206,2M USD | 28,0 % |
| AMPH | Amphastar Pharmaceuticals, Inc. | B+ | 1,2B USD | 28,61 USD | 13,06 | 745,8M USD | 13,3 % |
| HROW | Harrow, Inc. | D- | 1,1B USD | 29,30 USD | — | 303,3M USD | -9,4 % |
| BGM | BGM Group Ltd | F- | 985,4M USD | 8,70 USD | — | 47,9M USD | -44,2 % |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C+ | 804,6M USD | 4,86 USD | 5,40 | 400,3M USD | 37,4 % |
| COLL | Collegium Pharmaceutical, Inc. | B | 770,5M USD | 24,80 USD | 24,80 | 815,2M USD | 4,7 % |
| TKNO | ALPHA TEKNOVA, INC. | B- | 541,6M USD | 8,61 USD | — | 46M USD | -34,8 % |
| EOLS | EVOLUS, INC. | B | 492,1M USD | 7,44 USD | — | 325,5M USD | -9,6 % |
| KMDA | KAMADA LTD | C+ | 469,6M USD | 8,14 USD | 18,93 | 196,9M USD | 13,6 % |
| AQST | Aquestive Therapeutics, Inc. | D | 449,3M USD | 3,58 USD | — | 48,8M USD | -162,3 % |
| TLRY | Tilray Brands, Inc. | C- | 385M USD | 2,61 USD | — | 963,1M USD | -17,1 % |
| EBS | EMERGENT BIOSOLUTIONS INC. | D | 310,3M USD | 6,04 USD | — | 649,1M USD | -40,2 % |
| EVO | Evotec SE | F- | 304,9M USD | 1,72 USD | — | 836,2M USD | -26,0 % |
| ACB | AURORA CANNABIS INC | D- | 280,9M USD | 5,05 USD | 176,32 | 225,8M USD | -29,9 % |
| BIOA | BIOAGE LABS, INC. | F- | 268,9M USD | 5,85 USD | — | 8,6M USD | -1.253,6 % |
| CGC | Canopy Growth Corporation | C- | 256,3M USD | 0,61 USD | — | 219,2M USD | -87,0 % |
| LFCR | LIFECORE BIOMEDICAL, INC. | F | 242,4M USD | 6,40 USD | — | 128,9M USD | -30,0 % |
| SIGA | Siga Technologies INC | F | 225,6M USD | 3,14 USD | — | 52,4M USD | 1,3 % |
| INCR | INTERCURE LTD. | C- | 219,8M USD | 4,02 USD | — | 86,4M USD | -13,2 % |
| ADCT | ADC Therapeutics SA | C | 203,6M USD | 1,60 USD | — | 84,9M USD | -95,7 % |
| ANIK | Anika Therapeutics, Inc. | B- | 186,3M USD | 13,91 USD | — | 123,4M USD | -1,4 % |
| GLAS | Glass House Brands Inc. | F- | 165,5M USD | 1,90 USD | — | 152,9M USD | -33,7 % |
| AKBA | AKEBIA THERAPEUTICS, INC. | D | 158M USD | 0,57 USD | — | 197,2M USD | -22,6 % |
| ORGO | ORGANOGENESIS HOLDINGS INC. | F- | 136,3M USD | 1,05 USD | — | 352M USD | -38,4 % |
| DERM | Journey Medical Corp | C- | 125,7M USD | 4,46 USD | — | 68,2M USD | -9,0 % |
| CRDL | Cardiol Therapeutics Inc. | fără notă | 100,8M USD | 1,01 USD | — | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | 94,8M USD | 6,33 USD | — | 39,9M USD | -27,4 % |
| INM | INMED PHARMACEUTICALS INC. | F- | 85,5M USD | 15,56 USD | — | 4,5M USD | -292,1 % |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | 81,3M USD | 0,85 USD | — | 185,5M USD | -9,6 % |
| ZYBT | Zhengye Biotechnology Holding Limited | D | 72,3M USD | 1,53 USD | — | 17,5M USD | -60,0 % |
| CTOR | Citius Oncology, Inc. | fără notă | 51,7M USD | 0,56 USD | — | — | — |
| SCYX | SCYNEXIS INC | F- | 34,1M USD | 3,43 USD | — | 18,9M USD | -53,5 % |
| RMTI | ROCKWELL MEDICAL, INC. | B- | 28,7M USD | 7,13 USD | — | 72,6M USD | -7,8 % |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D- | 22,7M USD | 0,53 USD | — | 3,9M USD | -114,3 % |
| TXMD | TherapeuticsMD, Inc. | F- | 21,4M USD | 1,85 USD | — | 3,3M USD | -6,6 % |
| AYTU | AYTU BIOPHARMA, INC. | C | 19,7M USD | 1,82 USD | — | 57,6M USD | -24,8 % |
| RDHL | REDHILL BIOPHARMA LTD. | F | 17,9M USD | 0,40 USD | — | -3,7M USD | -72,5 % |
| TLPH | TALPHERA, INC. | D- | 15M USD | 1,05 USD | — | 1K USD | -1.465.800,0 % |
| BFRI | Biofrontera Inc. | B- | 13,9M USD | 0,93 USD | — | 46,2M USD | -13,8 % |
| SBFM | Sunshine Biopharma Inc. | D- | 10,7M USD | 2,76 USD | — | 35,3M USD | -16,5 % |
| CABR | Caring Brands, Inc. | F- | 9,2M USD | 0,88 USD | — | 4,2K USD | -183.255,2 % |
| IMCC | IM Cannabis Corp. | D | 7,2M USD | 0,56 USD | — | 32,8M USD | -40,1 % |
| SNOA | SONOMA PHARMACEUTICALS, INC. | C- | 6,2M USD | 1,23 USD | — | 23,5M USD | -7,6 % |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | fără notă | 5,4M USD | 5,32 USD | — | — | — |
| GELS | Gelteq Limited | D- | 4M USD | 0,43 USD | — | 116,4K USD | -4.011,9 % |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | fără notă | 3,4M USD | 2,28 USD | — | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | 2,8M USD | 2,89 USD | — | 1,1M USD | -545,2 % |
| YCBD | cbdMD, Inc. | D- | 1,6M USD | 0,39 USD | — | 20,9M USD | -13,8 % |
| IXHL | Incannex Healthcare Inc. | F- | 993,5K USD | 1,98 USD | — | 0,00 USD | — |
| UPC | Universe Pharmaceuticals INC | D- | 907K USD | 1,61 USD | — | 17,9B USD | -20,6 % |
| PRFX | PRF Technologies Ltd. | B- | 629,5K USD | 0,76 USD | — | 17K USD | -29.541,2 % |
| AKAN | Akanda Corp. | F | 50,4K USD | 0,73 USD | — | 258,1K USD | -19.775,5 % |
| INDV | Indivior Pharmaceuticals, Inc. | A | — | 28,15 USD | — | 1,4B USD | 32,8 % |
| OPTH | Optimi Health Corp. | fără notă | — | 2,19 USD | — | — | — |
Fundamente din raportările la SEC, prețuri de la ultima rulare de date de piață. Sortează după orice coloană; companiile fără cifră ajung la final în ambele sensuri.
Sortat după capitalizare, de la cea mai mare; apasă pe orice coloană ca să sortezi altfel. Companiile fără cifră ajung la final în ambele sensuri, pentru că un PER lipsă înseamnă pierdere, nu ieftinătate. Nimic de aici nu este o recomandare.